Edition:
United States

Capricor Therapeutics Inc (CAPR.OQ)

CAPR.OQ on NASDAQ Stock Exchange Capital Market

1.08USD
16 Aug 2018
Change (% chg)

-- (--)
Prev Close
$1.08
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
34,553
52-wk High
$4.25
52-wk Low
$0.97

Chart for

About

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapeutics. The Company focuses on discovering, developing and commercializing regenerative medicine and large molecule products for the treatment of disease, with a primary focus on the... (more)

Overall

Beta: -2.64
Market Cap(Mil.): $30.86
Shares Outstanding(Mil.): 29.11
Dividend: --
Yield (%): --

Financials

  CAPR.OQ Industry Sector
P/E (TTM): 13.38 99.04 30.20
EPS (TTM): -0.09 -- --
ROI: 33.55 3.31 12.77
ROE: 116.61 2.31 14.92

BRIEF-Capricor Therapeutics Reports Q1 Loss Per Share $0.14

* CAPRICOR THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 10 2018

BRIEF-Capricor Q4 Earnings Per Share $0.42

* CAPRICOR PRESENTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND CORPORATE UPDATE

Mar 14 2018

Earnings vs. Estimates